{"title":"バイオCDMO事業から視た創薬力の強化ポイント","authors":"Takatoshi Ishikawa","doi":"10.4091/iken.33-345","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":117299,"journal":{"name":"Iryo To Shakai","volume":"44 15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iryo To Shakai","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4091/iken.33-345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}